Top Shares in $243 Million Healthcare Sector Fund Portfolio: KCI, PFE, CEPH, GILD, TMO, AET, CBST

Wall St. Watchdog reveals information regarding Moore Capital’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 36 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $243.817 million.

  • Kinetic Concepts Inc. (NYSE:KCI): On 06/30/2011, Moore Capital reported holding 0 shares. On 09/30/2011, Moore Capital reported holding 844,865 shares with a market value of $55,668,154. This comprised 2.71% of the total portfolio. The net change in shares for this position over the two quarters is 844,865. About Company: Kinetic Concepts, Inc. designs, manufactures, markets, and services products that accelerate the healing process or prevent complications of wounds. The Company’s products include specialty hospital beds, and mattress replacements.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Moore Capital reported holding 815,000 shares with a market value of $16,789,000. This comprised 0.84% of the total portfolio. On 09/30/2011, Moore Capital reported holding 2,740,000 shares with a market value of $48,443,201. This comprised 2.36% of the total portfolio. The net change in shares for this position over the two quarters is 1,925,000. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Moore Capital reported holding 55,000 shares with a market value of $1,940,950. This comprised 0.1% of the total portfolio. On 09/30/2011, Moore Capital reported holding 919,000 shares with a market value of $30,051,301. This comprised 1.46% of the total portfolio. The net change in shares for this position over the two quarters is 864,000. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Cephalon Inc. (NASDAQ:CEPH): On 06/30/2011, Moore Capital reported holding 95,000 shares with a market value of $7,590,500. This comprised 0.38% of the total portfolio. On 09/30/2011, Moore Capital reported holding 225,000 shares with a market value of $18,157,499. This comprised 0.89% of the total portfolio. The net change in shares for this position over the two quarters is 130,000. About Company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Moore Capital reported holding 550,000 shares with a market value of $22,775,500. This comprised 1.13% of the total portfolio. On 09/30/2011, Moore Capital reported holding 400,000 shares with a market value of $15,520,000. This comprised 0.76% of the total portfolio. The net change in shares for this position over the two quarters is -150,000. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Moore Capital reported holding 50,000 shares with a market value of $3,938,500. This comprised 0.2% of the total portfolio. On 09/30/2011, Moore Capital reported holding 175,728 shares with a market value of $11,471,524. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is 125,728. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Moore Capital reported holding 250,000 shares with a market value of $16,097,500. This comprised 0.8% of the total portfolio. On 09/30/2011, Moore Capital reported holding 175,000 shares with a market value of $8,862,000. This comprised 0.43% of the total portfolio. The net change in shares for this position over the two quarters is -75,000. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Aetna Inc. (NYSE:AET): On 06/30/2011, Moore Capital reported holding 375,000 shares with a market value of $16,533,750. This comprised 0.82% of the total portfolio. On 09/30/2011, Moore Capital reported holding 190,582 shares with a market value of $6,925,750. This comprised 0.34% of the total portfolio. The net change in shares for this position over the two quarters is -184,418. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Intermune Inc. (NASDAQ:ITMN): On 06/30/2011, Moore Capital reported holding 265,000 shares with a market value of $9,500,250. This comprised 0.47% of the total portfolio. On 09/30/2011, Moore Capital reported holding 325,000 shares with a market value of $6,565,000. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 60,000. About Company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease
  • Cubist Pharmaceuticals Inc. (NASDAQ:CBST): On 06/30/2011, Moore Capital reported holding 275,000 shares with a market value of $9,897,250. This comprised 0.49% of the total portfolio. On 09/30/2011, Moore Capital reported holding 175,000 shares with a market value of $6,181,000. This comprised 0.3% of the total portfolio. The net change in shares for this position over the two quarters is -100,000. About Company: Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company’s lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.

(Note: Data regarding Moore Capital’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet